Login

Symposium Agenda

Symposium Chair: Mark A. Ware, Canada

Time
Topic
Speaker
0730-0830
Registration, Poster set-up and Continental Breakfast
0830-0845
Welcome
Session 1. Fundamentals of cannabinoid neuroscience
0845-0915
Pharmacological strategies for targeting cannabinoid receptors in the clinic
Roger Pertwee, UK
0915-0945
Endogenous cannabinoids and pain
Andrea Hohmann, USA
0945-1015
Opioids and Cannabinoids Interactions: Involvement in Pain Management
Pierre Beaulieu, Canada
1015-1030
Panel discussion
1030-1045
Coffee break
Session 2. Cannabinoids and comorbidity
1045-1115
Cannabinoids and depression
Matt Hill, USA
1115-1145
Cannabinoid receptor-TRP channel
interactions in pain and inflammation
Vincenzo Di Marzo, Italy
1145-1200
Panel discussion
1200-1300
Lunch
Session 3. Cannabinoids in clinical practice
1300-1330
Cannabinoids in cancer pain
Paul Daeninck, Canada
1330-1400
Tapping into the endocannabinoid system to alleviate osteoarthritis pain
Jason McDougall, Canada
1400-1430
Cannabinoids in HIV/AIDS
Donald Abrams, USA
1430-1445
Panel discussion
1445-1500
Coffee break
Session 4. Cannabinoids and the future 
1500-1520
CB2 agonists and peripherally restricted CB1 agonists for pain: Do they still hold promises?
Thierry Groblewski, AstraZeneca
1520-1540
Selective fatty acid amide inhibition for the treatment of chronic pain
Tim Young, Pfizer
1540-1600
Sativex, and the Phytocannabinoid Pipeline for Pain Control
Ethan Russo, GW
1600-1700
Round table discussion:
Future of cannabinoid research
Mark A. Ware, Canada
(Moderator)
1700-1715
Closing remarks
1715-1900
Poster session and Reception

 

Updated August 9, 2010

Faculty:

  • Donald Abrams, USA
  • Pierre Beaulieu, Canada
  • Paul Daeninck, Canada
  • Vincenzo Di Marzo, Italy
  • Matthew Hill, USA
  • Andrea Hohmann, USA
  • Jason McDougall, Canada
  • Roger Pertwee, UK
  • Mark Ware, Canada